Maharashtra’s government suspends four FDA officials following allegations of lapses in how regulators acted in cases involving tobacco products. The suspensions are linked to irregularities connected to action taken against two companies accused of possessing banned tobacco products.
Alongside the suspensions, the state launches a departmental inquiry. One report says the government suspends the four officers while initiating an internal probe involving 21 other FDA personnel, indicating the issue extends beyond the immediately suspended staff. The two outlets both emphasize the suspension and the hookah/tobacco-related context, but they differ in the level of detail: one also describes the broader scope of the inquiry and the reference to “two companies” and “banned tobacco products,” while the other focuses more narrowly on “hookah tobacco lapses.”